Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹1,608 Cr₹1,565 Cr₹1,398 Cr₹729 Cr₹582 Cr

What is the latest Total Current Liabilities ratio of GLAND PHARMA ?

The latest Total Current Liabilities ratio of GLAND PHARMA is ₹1,608 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹1,608 Cr
Mar2025₹1,565 Cr
Mar2024₹1,398 Cr
Mar2023₹729 Cr
Mar2022₹582 Cr

How is Total Current Liabilities of GLAND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2026 ₹1,608 Cr
2.78
Mar2025 ₹1,565 Cr
11.91
Mar2024 ₹1,398 Cr
91.78
Mar2023 ₹729 Cr
25.28
Mar2022 ₹582 Cr -

Compare Total Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,941.6 Cr 2.9% 19.7% 45.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.9%

19.7%

45.1%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses